Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
暂无分享，去创建一个
Jeffrey A. Cohen | D. Arnold | H. Hartung | E. Fisher | E. Havrdová | K. Selmaj | A. Coles | C. Confavreux | M. Panzara | D. Margolin | R. Sandbrink | E. Fox | D. Compston | T. Miller | C. Twyman | P. Oyuela | H. Weiner | S. Lake | Rupert Sandbrink | J. Cohen | Jeffrey A. Cohen